Spruce Biosciences, Inc. (SPRB) Free cash flow 2019–2024
Spruce Biosciences, Inc. (SPRB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$56.0MFY2024 · since FY2019: -$12.6M → -$56.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$56.0M | -68.2% |
| FY2023 | -$33.3M | +20.2% |
| FY2022 | -$41.7M | -15.9% |
| FY2021 | -$36.0M | -30.4% |
| FY2020 | -$27.6M | -118.6% |
| FY2019 | -$12.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice